Methionine

Europe PMC · fetched just now · sorted by publication date

1. 1
   Advances and perspectives in genetically encoded biosensors for biomarker detection and theranostic circuits.

   Xu J, Qi Q, Wang Q. · 2026-09-23

   open access unreviewed
2. 2
   Systems-level analysis of 1,6-hexanediol stress response and tolerance engineering in <i>Escherichia coli</i>.

   Zhang X, Qin L, Li H, Wang X, Chen K. · 2026-08-15

   open access unreviewed
3. 3
   Reassigning an amber codon to selenocysteine using a functional cysteine suppression pair in <i>Escherichia coli</i>.

   Niu S, Wei J, Li M, Guo B, Yan Q, Huang Y, Jiang Z, Song J. · 2026-07-29

   open access unreviewed
4. 4
   Biomaterials for intervertebral disc regeneration: Niche reprogramming, precision therapeutics, and structural reconstruction.

   Jiang Y, Li H, Wang W, Guo Q, Wang C, Li Y, Lu H, Chen J, Yang H, Zhao X, Zheng L, Qiao Y. · 2026-09-03

   open access unreviewed
5. 5
   Bioactive glasses-mediated ion therapy ameliorates hepatic osteodystrophy by reprogramming the liver-bone axis.

   Liu SC, Xie E, Zhao P, Liu YS, Xie ZY, Chang HD, Zhao WD, Huang PY, Zhu YX, Rehman MAU, Gao Y, Urbani L, Gou … · 2026-08-31

   open access unreviewed
6. 6
   Quercetin-derived carbon dots-modified ZIF-8 and M2 macrophage-derived migrasomes-functionalized microenvironment-responsive nanocomposite hydrogel for osteoporotic bone defects regeneration.

   Yin H, Li Y, Zhu Y, Yan Z, Han Y, Cheng F, Hu J, Ma J, Xing X, Yang C, Tian H, Chen W, Zhang Y. · 2026-08-30

   open access unreviewed
7. 7
   ONC201/dordaviprone for H3 K27M-mutant tumors: Discovery, mechanisms, therapeutic potential, and future directions.

   Pimentel JM, Zhou JY, Wu GS. · 2026-06-24

   open access unreviewed
8. 8
   Metabolic reprogramming in colorectal cancer: Mechanisms and therapeutic insights.

   Xiao W, Tan D, Zeng W, Nie X, Wang M. · 2026-01-28

   open access unreviewed
9. 9
   Clinical and iPSC-based characterization of the HNF1A p.T82M variant.

   Liu R, Murusuri AB, Huang S, Dai Z, Jiang W, Tang J. · 2026-02-13

   open access unreviewed
10. 10
    A universal consuming endogenous H<sub>2</sub>S strategy using bismuth-metal-organic nanocapsule networks for overcoming osteosarcoma cisplatin resistance.

    Lin Y, Yuan K, Liu Y, Du Y, Chang H, Hou L, Liang Y, Huang K, Yang S, Tang T. · 2026-08-18

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.